Could This Move by Moderna Cost Pfizer Billions?

Could This Move by Moderna Cost Pfizer Billions?

Source: 
Motley Fool
snippet: 
  • Pfizer and BioNTech have generated billions of dollars in revenue from their coronavirus vaccine.
  • But rival Moderna says they’ve infringed on Moderna patents. Moderna is suing the companies in the U.S. and Germany.
  • The outcome of this challenge could impact the companies’ vaccine revenue today and into the future.